Stephanie Okey - Net Worth and Insider Trading

Stephanie Okey Net Worth

The estimated net worth of Stephanie Okey is at least $435,986 dollars as of 2024-11-13. Stephanie Okey is the Director of Crinetics Pharmaceuticals Inc and owns about 6,000 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $352,680. Stephanie Okey is also the Director of PTC Therapeutics Inc and owns about 1,867 shares of PTC Therapeutics Inc (PTCT) stock worth over $83,306. Details can be seen in Stephanie Okey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephanie Okey has not made any transactions after 2024-03-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Stephanie Okey

To

Stephanie Okey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephanie Okey owns 4 companies in total, including Albireo Pharma Inc (ALBO) , Crinetics Pharmaceuticals Inc (CRNX) , and PTC Therapeutics Inc (PTCT) among others .

Click here to see the complete history of Stephanie Okey’s form 4 insider trades.

Insider Ownership Summary of Stephanie Okey

Ticker Comapny Transaction Date Type of Owner
ALBO Albireo Pharma Inc 2018-06-08 director
CRNX Crinetics Pharmaceuticals Inc 2024-03-28 director
PTCT PTC Therapeutics Inc 2022-08-09 director
LIMIT LIMIT 2023-08-28 director

Stephanie Okey Latest Holdings Summary

Stephanie Okey currently owns a total of 2 stocks. Among these stocks, Stephanie Okey owns 6,000 shares of Crinetics Pharmaceuticals Inc (CRNX) as of March 28, 2024, with a value of $352,680 and a weighting of 80.89%. Stephanie Okey also owns 1,867 shares of PTC Therapeutics Inc (PTCT) as of August 9, 2022, with a value of $83,306 and a weighting of 19.11%.

Latest Holdings of Stephanie Okey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRNX Crinetics Pharmaceuticals Inc 2024-03-28 6,000 58.78 352,680
PTCT PTC Therapeutics Inc 2022-08-09 1,867 44.62 83,306

Holding Weightings of Stephanie Okey


Stephanie Okey Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephanie Okey has made a total of 1 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 17,500 shares on March 28, 2024, which brought Stephanie Okey around $811,650.

According to the SEC Form 4 filings, Stephanie Okey has made a total of 3 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 2,296 shares on August 9, 2022, which brought Stephanie Okey around $118,520.

Insider Trading History of Stephanie Okey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephanie Okey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephanie Okey Ownership Network

Ownership Network List of Stephanie Okey

No Data

Ownership Network Relation of Stephanie Okey

Insider Network Chart

Stephanie Okey Owned Company Details

What does Albireo Pharma Inc do?

Who are the key executives at Albireo Pharma Inc?

Stephanie Okey is the director of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .

Albireo Pharma Inc (ALBO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Albireo Pharma Inc Insider Transactions

No Available Data

Stephanie Okey Mailing Address

Above is the net worth, insider trading, and ownership report for Stephanie Okey. You might contact Stephanie Okey via mailing address: C/o Albireo Pharma, Inc., 10 Post Office Square, Suite 502 South, Boston Ma 02109.